Colorectal cancer – Life with Disease

Go back

Colorectal cancer is a disease that begins in the colon or rectum, parts of the digestive system responsible for processing waste and nutrients. While it ranks among the most common cancers worldwide, understanding its impact, progression, and how to live with it can help patients and families navigate this challenging journey with greater confidence and clarity.

Understanding the Outlook: Prognosis and Survival

When someone receives a diagnosis of colorectal cancer, one of the first questions that often comes to mind is about the future. The prognosis, or expected outcome, depends heavily on how early the cancer is discovered and how far it has spread at the time of diagnosis. This is why screening is so important—it can catch cancer when it’s most treatable.

The good news is that survival rates for colorectal cancer have improved significantly over recent decades. According to available data, when the disease is found early—at stages I or II—approximately nine out of ten people live beyond five years from diagnosis. This means that catching the disease before it spreads gives patients an excellent chance of long-term survival. The five-year survival rate for early-stage disease can be as high as 91%, which offers real hope to those diagnosed early.

However, the picture changes as the disease progresses. For stage III colorectal cancer, where the cancer has spread to nearby lymph nodes or organs, the outlook becomes more guarded. By the time the disease reaches stage IV, when it has spread to distant parts of the body like the liver or lungs, the five-year survival rate drops to about 13%. This dramatic difference underscores why early detection matters so much—it can literally be the difference between a very favorable outcome and a much more challenging one.

It’s important to understand that these statistics represent averages across large groups of people. Every person’s cancer is unique, influenced by factors like the specific characteristics of the tumor, overall health, age, and how well the cancer responds to treatment. Some people do better than the averages suggest, while others face more difficulties. Your healthcare team can provide a more personalized understanding of prognosis based on your specific situation.

⚠️ Important
Statistics about survival are based on past data and may not reflect the most recent treatment advances. New therapies, including targeted treatments and immunotherapies, are changing outcomes for many patients. Your individual circumstances matter more than any statistic, so have open conversations with your medical team about what to expect.

How Colorectal Cancer Develops Without Treatment

Understanding how colorectal cancer progresses naturally helps explain why timely treatment is so critical. The disease doesn’t appear overnight—it typically develops slowly over many years, often beginning with small growths called polyps on the inner lining of the colon or rectum. Polyps are clusters of cells that form on the intestinal wall, and while most are harmless, some can transform into cancer over time.

This transformation usually takes about ten to fifteen years, which is why colorectal cancer often doesn’t cause symptoms in its earliest stages. The polyps may grow without causing any noticeable problems, silently developing into cancerous tissue. This slow progression is actually advantageous for prevention—it gives people a long window of time during which screening tests can find and remove polyps before they become dangerous.

If left untreated, colorectal cancer follows a predictable pattern of growth. It starts in the innermost layer of the colon or rectum wall, called the mucosa, which is made up of cells that produce mucus and other fluids. As cancer cells multiply and become more aggressive, they begin to invade deeper layers of the intestinal wall, pushing through tissue and muscle. Eventually, the cancer can break through the outer layer of the colon or rectum entirely.

Once the cancer penetrates the intestinal wall completely, it gains access to nearby structures. It may spread to nearby organs or tissues, and cancer cells can enter the lymphatic system—a network of vessels that carries fluid throughout the body. This allows cancer cells to travel to lymph nodes near the colon or rectum. From there, the disease can spread even further, entering the bloodstream and traveling to distant organs like the liver, lungs, or even the brain. This process of spreading beyond the original site is called metastasis.

Without treatment, symptoms gradually worsen as the tumor grows larger and interferes with normal bowel function. The cancer may eventually block the intestine, making it difficult or impossible for waste to pass through. As the disease spreads to other organs, those organs begin to malfunction as well. This progressive deterioration is why treatment at any stage—even advanced disease—remains important for maintaining quality of life and potentially extending survival.

Possible Complications and What Can Go Wrong

Colorectal cancer can lead to various complications, both from the disease itself and occasionally from the treatments used to fight it. Understanding these potential problems helps patients recognize warning signs and seek help promptly when something doesn’t feel right.

One of the most serious complications is bowel obstruction. As a tumor grows within the colon or rectum, it can narrow the passageway through which waste normally travels. This can lead to severe constipation, complete inability to have a bowel movement, intense abdominal pain, bloating, nausea, and vomiting. A complete blockage is a medical emergency requiring immediate attention, as waste can back up and cause dangerous complications including perforation of the intestinal wall.

Bleeding is another common complication. Colorectal tumors can bleed as they grow, sometimes causing visible blood in the stool that appears bright red or makes the stool look dark and tarry. While small amounts of bleeding might go unnoticed at first, chronic blood loss over time can lead to anemia, a condition where the body doesn’t have enough healthy red blood cells to carry oxygen effectively. People with anemia often feel extremely tired, weak, short of breath, and may appear pale.

When colorectal cancer spreads to other organs, it creates additional complications specific to those areas. If cancer spreads to the liver, it can interfere with the liver’s ability to filter toxins from the blood and produce essential proteins. Liver metastases can cause jaundice (yellowing of the skin and eyes), abdominal swelling, and confusion. Cancer that spreads to the lungs may cause persistent cough, shortness of breath, chest pain, or coughing up blood. Spread to the bones can cause significant pain and increase the risk of fractures.

The cancer can also affect the area around the intestines. It may grow into the peritoneum, the membrane lining the abdominal cavity, causing a condition called peritoneal carcinomatosis. This can lead to fluid buildup in the abdomen, difficulty eating, and digestive problems. In some cases, the tumor can create abnormal connections called fistulas between the intestine and other organs or the skin, leading to infections and other serious problems.

Treatment-related complications can also occur. Surgery can lead to infection, bleeding, or problems with how the intestines heal after being reconnected. Chemotherapy often causes side effects like nausea, fatigue, numbness in the hands and feet, and increased risk of infection due to low white blood cell counts. Radiation therapy to the pelvic area can cause bowel irritation, diarrhea, and long-term changes in bowel function. While these complications sound frightening, medical teams are skilled at preventing, managing, and treating them when they arise.

How Colorectal Cancer Affects Daily Life

Living with colorectal cancer touches every aspect of a person’s life, far beyond the physical symptoms and medical appointments. The disease and its treatment create challenges that ripple through daily routines, relationships, work, and emotional well-being.

Physically, many people with colorectal cancer experience changes in their bowel habits that can be unpredictable and distressing. Some struggle with frequent diarrhea, while others battle constipation. The urgency to use the bathroom can make it difficult to leave home for extended periods, affecting the ability to work, shop, or socialize. Those who have surgery may need to adjust to having a colostomy or ileostomy—an opening in the abdomen that allows waste to collect in a bag outside the body. While these ostomies enable people to live full lives, they require learning new care techniques and adjusting to body changes.

Fatigue is one of the most common and underestimated effects of colorectal cancer. It’s not just ordinary tiredness that a good night’s sleep can fix—it’s a deep, persistent exhaustion that affects the ability to concentrate, work, and enjoy activities. Cancer-related fatigue can come from the disease itself, from treatments like chemotherapy and radiation, from anemia due to bleeding, or from the emotional stress of dealing with cancer. Simple tasks like cooking a meal or taking a shower can feel overwhelming.

The emotional and mental impact can be profound. Many people experience fear about the future, worry about how their illness affects loved ones, and anxiety about treatment outcomes. Depression is common among cancer patients, particularly when facing the reality of a serious illness and the possibility of death. Some people feel angry or frustrated about why this happened to them, while others struggle with feelings of isolation, especially if symptoms make them feel embarrassed or different from healthy friends and family.

Work life often requires significant adjustments. Treatment schedules may demand time off for surgery, chemotherapy sessions, radiation appointments, and recovery periods. Side effects like fatigue, bowel urgency, or “chemo brain” (difficulty with memory and concentration) can make it hard to perform job duties at previous levels. Some people need to reduce their hours, take disability leave, or even stop working entirely. This creates financial stress in addition to the emotional challenges of losing a sense of purpose and routine that work provides.

Social relationships and intimate life can change dramatically. Some friends may not know how to respond to a cancer diagnosis and might pull away, while others become invaluable sources of support. Romantic relationships face unique pressures—partners must navigate fear, changing roles, and the stress of caregiving alongside their own emotional responses. Sexual function can be affected by surgery, particularly for rectal cancer, as well as by fatigue, body image concerns, and the general stress of illness. Open communication with partners and healthcare providers about these sensitive topics is crucial but can be difficult.

Many people find ways to cope and adapt. Practical strategies include planning activities around times when energy is highest, keeping bathroom supplies easily accessible, and building a support network of family, friends, and fellow patients. Some find comfort in support groups where they can talk with others who truly understand what they’re going through. Others benefit from counseling or therapy to process emotions and develop coping skills. Maintaining some normalcy—whether through hobbies adapted to current abilities, gentle exercise when possible, or simply maintaining regular contact with loved ones—can provide important psychological benefits.

⚠️ Important
Changes in daily life don’t mean giving up on quality of life. Many people with colorectal cancer continue to work, travel, enjoy hobbies, and maintain meaningful relationships. It requires adjustments and flexibility, but with support and the right resources, it’s possible to create a new normal that includes joy and purpose alongside the challenges of cancer.

Supporting Families Through Clinical Trials

Clinical trials represent an important option in colorectal cancer care, and family members can play a vital role in helping patients explore and participate in these research studies. Understanding what clinical trials are and how they work helps families provide meaningful support during this decision-making process.

Clinical trials are carefully designed research studies that test new treatments, procedures, or ways of using existing therapies. For colorectal cancer, these might include experimental drugs, new combinations of existing medications, innovative surgical techniques, or novel approaches like immunotherapy. Participating in a trial gives patients access to cutting-edge treatments that aren’t yet available to the general public, and it also contributes to medical knowledge that may help future patients.

Families can help by researching clinical trial opportunities. There are online databases and resources that list active trials for colorectal cancer, searchable by location and cancer stage. Family members can gather information about eligible trials, read about what they involve, and compile questions to discuss with the medical team. This research can feel overwhelming to a patient dealing with the physical and emotional burden of cancer, so having someone else take on this task can be tremendously helpful.

Understanding the potential benefits and risks of trial participation is crucial. Clinical trials follow strict protocols designed to protect participants, but they also involve unknowns—that’s the nature of research. The treatment being studied might work better than standard therapy, the same as standard therapy, or potentially not as well. There may be unexpected side effects. Families can help by asking doctors to explain these possibilities clearly, ensuring the patient has realistic expectations about what participating might mean.

The practical aspects of clinical trial participation often require family support. Trials typically involve more frequent clinic visits, additional tests and monitoring, detailed record-keeping, and strict adherence to the study protocol. Family members can help with transportation to appointments, attending clinic visits to take notes and ask questions, organizing medications and schedules, and providing emotional support through the additional demands of trial participation.

Families should also understand that participating in a clinical trial is always voluntary, and patients can withdraw at any time without affecting their right to receive standard care. This decision belongs to the patient, though input from trusted family members can help them think through the options. Some patients feel motivated by the opportunity to advance science and potentially help others, even if they don’t personally benefit. Others prefer the certainty of standard treatments. Both choices are valid, and families can best support by respecting the patient’s decision whatever it may be.

Financial considerations are another area where families can provide support. Many clinical trials cover the costs of the experimental treatment and related care, but participants may still have expenses for travel, lodging if the trial site is far from home, or other out-of-pocket costs. Families can help by investigating what the trial covers, exploring financial assistance programs, and helping plan for any additional expenses that might arise.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Bevacizumab – A targeted therapy that works by preventing the formation of new blood vessels that tumors need to grow.
  • Ramucirumab – A targeted therapy that blocks blood vessel formation crucial for tumor growth.
  • Cetuximab – A targeted therapy that targets specific protein receptors on cancer cells to stop tumor cell division and growth.
  • Regorafenib – A newer targeted therapy drug that blocks multiple signaling pathways that tumors use for survival.
  • Encorafenib – A targeted therapy that specifically targets abnormal BRAF proteins found in colorectal cancer cells.

Ongoing Clinical Trials on Colorectal cancer

  • Study of organ preservation using chemoradiotherapy and transanal surgery compared to standard surgery in patients with early rectal cancer (STAR-TREC trial)

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands Sweden
  • Study of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma

    Not recruiting

    1 1 1 1
    Spain
  • Study of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Belgium Spain
  • Study of Pembrolizumab and Olaparib for Patients with Advanced Colorectal Cancer with DNA Repair Deficiency

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study of JDQ443 and Ribociclib in Combination for Adult Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Not recruiting

    1 1 1 1
    Belgium France Germany Italy Spain
  • Study of Oxaliplatin and Nivolumab for Patients with Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Norway
  • Study of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer

    Not recruiting

    2 1 1 1
    Germany
  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy The Netherlands Poland Spain

References

https://www.cdc.gov/colorectal-cancer/about/index.html

https://www.cancer.org/cancer/types/colon-rectal-cancer/about/what-is-colorectal-cancer.html

https://www.mayoclinic.org/diseases-conditions/colon-cancer/symptoms-causes/syc-20353669

https://www.ncbi.nlm.nih.gov/books/NBK586003/

https://colorectalcancer.org/basics-what-colorectal-cancer

https://my.clevelandclinic.org/health/diseases/14501-colorectal-colon-cancer

https://coloncancercoalition.org/colon-cancer-screening/facts/

https://medlineplus.gov/colorectalcancer.html

https://www.aacr.org/patients-caregivers/cancer/colorectal-cancer/

https://www.mayoclinic.org/diseases-conditions/colon-cancer/diagnosis-treatment/drc-20353674

https://www.cancer.org/cancer/types/colon-rectal-cancer/treating.html

https://www.cancer.gov/types/colorectal/patient/colon-treatment-pdq

https://pmc.ncbi.nlm.nih.gov/articles/PMC10190721/

https://cancer.ca/en/cancer-information/cancer-types/colorectal/treatment

https://my.clevelandclinic.org/health/diseases/14501-colorectal-colon-cancer

https://www.cancerresearch.org/blog/fighting-colorectal-cancer-with-immunotherapy-what-you-need-to-know

https://www.mskcc.org/news/new-colorectal-cancer-treatments-at-msk-aim-to-reduce-deaths-in-2025-and-beyond

https://www.massgeneralbrigham.org/en/about/newsroom/articles/stage-4-colorectal-cancer

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/treatment

https://www.cancer.org/cancer/types/colon-rectal-cancer/after-treatment/living.html

https://arizonaoncology.com/blog/living-as-a-colorectal-cancer-survivor-what-you-need-to-know/

https://nyulangone.org/conditions/colorectal-cancer/prevention

https://www.cdc.gov/colorectal-cancer/prevention/index.html

https://fightcolorectalcancer.org/resource/resource-library/guide-in-the-fight/lifestyle/

https://www.eatright.org/health/health-conditions/cancer/navigating-colorectal-cancer

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/living-with

https://www.uchealth.com/en/media-room/articles/foods-that-fight-colorectal-cancer-a-guide-to-nutrition-for-prevention-and-treatment

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What is the difference between colon cancer and colorectal cancer?

Colorectal cancer is an umbrella term that includes both colon cancer and rectal cancer. Cancer that begins in the colon (the large intestine) is called colon cancer, while cancer starting in the rectum (the passageway connecting the colon to the anus) is called rectal cancer. They are often grouped together because they share similar characteristics, but treatment may differ depending on the exact location.

Can colorectal cancer be prevented?

While not all colorectal cancers can be prevented, many can be. Regular screening starting at age 45 can find polyps before they turn into cancer, and removing these polyps prevents cancer from developing. Lifestyle changes like maintaining a healthy weight, eating a diet rich in fruits, vegetables, and whole grains, limiting red and processed meat, exercising regularly, avoiding tobacco, and limiting alcohol can also reduce your risk.

Why is my doctor recommending screening at 45 when I feel perfectly healthy?

Colorectal cancer often develops without causing any symptoms, especially in the early stages. Polyps and early-stage cancer usually don’t cause noticeable problems, which is exactly why screening is so important. By the time symptoms appear, the cancer may have already advanced. Screening can find disease early when it’s most treatable, or even prevent cancer entirely by removing polyps before they become dangerous.

Does having a family history of colorectal cancer mean I will definitely get it?

Having a family history increases your risk—if a parent, sibling, or child has had colorectal cancer, your risk is 2 to 3 times higher than someone without family history. However, this doesn’t mean you will definitely develop the disease. It means you should be more vigilant about screening, possibly starting at a younger age, and discuss your family history with your doctor to develop an appropriate monitoring plan.

What should I do if I notice blood in my stool?

Blood in the stool should always be evaluated by a healthcare provider, even though it doesn’t automatically mean you have colorectal cancer. Many other conditions like hemorrhoids, anal tears, or inflammatory bowel disease can cause bleeding. However, because bleeding can be a sign of cancer, it’s important not to dismiss it or assume it’s something harmless. Contact your doctor to describe the symptoms and schedule an examination.

🎯 Key takeaways

  • Early detection dramatically changes outcomes—91% of people survive at least five years when colorectal cancer is found at stages I or II, compared to just 13% when diagnosed at stage IV.
  • Colorectal cancer develops slowly over 10-15 years from polyps, providing a long window for prevention through screening starting at age 45.
  • The disease can cause serious complications including bowel obstruction, chronic bleeding leading to anemia, and spread to organs like the liver and lungs.
  • Living with colorectal cancer affects far more than physical health—it impacts work, relationships, daily routines, and emotional well-being in profound ways.
  • Younger people are developing colorectal cancer at increasing rates, with 30% of diagnoses now occurring in people under 55.
  • Family support during clinical trial participation can be invaluable, from researching opportunities to managing logistics and providing emotional encouragement.
  • Lifestyle modifications including diet, exercise, maintaining healthy weight, and avoiding tobacco and excessive alcohol can help reduce colorectal cancer risk.
  • New targeted therapies and immunotherapies are changing treatment outcomes, offering hope beyond traditional chemotherapy and surgery options.

Connected medications: